
Le 2011 Universal Biotech Innovation global Prize of 50.000 € (including cash and services), was awarded to the French company MTP Therapeutics(1) for having developed a new anti-cancer drug for the treatment of solid tumors. The lead compound, called pTM-NRP1, targets Neuropilin-1 receptor and co-receptors which have a pivotal role in endothelial and tumour cell migration. The innovative potential, the interest of the finding and the strength of the industrial property have rewarded the work of this French research team.
The mobilization of the jury members and the support of the industrial and institutional partners contributed to the success of the 2011 Innovation Prize, meeting the initial objective, i.e. the promotion and the development of winning alliances between biopharmaceutical public and private sectors.
The awarding ceremony was held in Paris, during the Innovation Days on the 27th of September 2011. The event, dedicated to the promotion of biomedical research, gathered about 450 participants and 54 speakers, leading conferences, round tables and workshops. Following the success of the 2011 edition, the 3rd edition of Innovation Days will take place at the Cité Internationale Universitaire of Paris, on October, 1st, 2nd and 3rd 2012.
No comments:
Post a Comment